Targeting the PI3K Akt signaling pathway in pancreatic $\beta$-cells to enhance their survival and function: an emerging therapeutic strategy for type 1 diabetes

Sheila Donnelly

Targeting the PI3K Akt signaling pathway in pancreatic $\beta$-cells to enhance their survival and function: an emerging therapeutic strategy for type 1 diabetes

Infectious Disease

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

Original language	English (Ireland)
Number of pages	13
Journal	Journal of Diabetes
Volume	14
Issue number	4
Publication status	Published - 1 Jan 2022

Authors (Note for portal: view the doc link for the full list of authors)

Authors
Camaya, Inah and Donnelly, Sheila and O'Brien, Bronwyn

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{ed92327100f0413885ae7a1fd7eb5be9,

title = "Targeting the PI3K Akt signaling pathway in pancreatic $\beta$-cells to enhance their survival and function: an emerging therapeutic strategy for type 1 diabetes",

author = "Sheila Donnelly",

year = "2022",

month = jan,

day = "1",

language = "English (Ireland)",

volume = "14",

journal = "Journal of Diabetes",

number = "4",

}